Jacobson TA - Search Results

1

Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment.

Weintraub WS, Bhatt DL, Zhang Z, Dolman S, Boden WE, Bress AP, King JB, Bellows BK, Tajeu GS, Derington CG, Johnson J, Andrade K, Steg PG, Miller M, Brinton EA, Jacobson TA, Tardif JC, Ballantyne CM, Kolm P. Weintraub WS, et al. Among authors: jacobson ta. JAMA Netw Open. 2022 Feb 1;5(2):e2148172. doi: 10.1001/jamanetworkopen.2021.48172. JAMA Netw Open. 2022. PMID: 35157055 Free PMC article.

2

Reducing high blood cholesterol level with drugs. Cost-effectiveness of pharmacologic management.

Schulman KA, Kinosian B, Jacobson TA, Glick H, Willian MK, Koffer H, Eisenberg JM. Schulman KA, et al. Among authors: jacobson ta. JAMA. 1990 Dec 19;264(23):3025-33. JAMA. 1990. PMID: 2123013 Review.

3

Cost-effectiveness of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor therapy in the managed care era.

Jacobson TA. Jacobson TA. Am J Cardiol. 1996 Sep 26;78(6A):32-41. doi: 10.1016/s0002-9149(96)00660-1. Am J Cardiol. 1996. PMID: 8875973

4

Maximizing the cost-effectiveness of lipid-lowering therapy.

Jacobson TA, Schein JR, Williamson A, Ballantyne CM. Jacobson TA, et al. Arch Intern Med. 1998 Oct 12;158(18):1977-89. doi: 10.1001/archinte.158.18.1977. Arch Intern Med. 1998. PMID: 9778197 Review.

5

Impact of evidence-based "clinical judgment" on the number of American adults requiring lipid-lowering therapy based on updated NHANES III data. National Health and Nutrition Examination Survey.

Jacobson TA, Griffiths GG, Varas C, Gause D, Sung JC, Ballantyne CM. Jacobson TA, et al. Arch Intern Med. 2000 May 8;160(9):1361-9. doi: 10.1001/archinte.160.9.1361. Arch Intern Med. 2000. PMID: 10809042

6

Characteristics of US adults with the metabolic syndrome and therapeutic implications.

Jacobson TA, Case CC, Roberts S, Buckley A, Murtaugh KM, Sung JC, Gause D, Varas C, Ballantyne CM. Jacobson TA, et al. Diabetes Obes Metab. 2004 Sep;6(5):353-62. doi: 10.1111/j.1462-8902.2004.00354.x. Diabetes Obes Metab. 2004. PMID: 15287928

7

Predictors of medication self-management skill in a low-literacy population.

Kripalani S, Henderson LE, Chiu EY, Robertson R, Kolm P, Jacobson TA. Kripalani S, et al. Among authors: jacobson ta. J Gen Intern Med. 2006 Aug;21(8):852-6. doi: 10.1111/j.1525-1497.2006.00536.x. J Gen Intern Med. 2006. PMID: 16881946 Free PMC article.

8

Hypertriglyceridemia and cardiovascular risk reduction.

Jacobson TA, Miller M, Schaefer EJ. Jacobson TA, et al. Clin Ther. 2007 May;29(5):763-777. doi: 10.1016/j.clinthera.2007.05.002. Clin Ther. 2007. PMID: 17697898 Review.

9

Myopathy with statin-fibrate combination therapy: clinical considerations.

Jacobson TA. Jacobson TA. Nat Rev Endocrinol. 2009 Sep;5(9):507-18. doi: 10.1038/nrendo.2009.151. Epub 2009 Jul 28. Nat Rev Endocrinol. 2009. PMID: 19636324 Review.

10

The importance of non-HDL cholesterol reporting in lipid management.

Blaha MJ, Blumenthal RS, Brinton EA, Jacobson TA; National Lipid Association Taskforce on Non-HDL Cholesterol. Blaha MJ, et al. Among authors: jacobson ta. J Clin Lipidol. 2008 Aug;2(4):267-73. doi: 10.1016/j.jacl.2008.06.013. Epub 2008 Jun 28. J Clin Lipidol. 2008. PMID: 21291742

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

209 results

Search Page